Oscar Health, Inc. (OSCR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oscar Health, Inc. on March 2, 2026. The filing serves as a Regulation FD disclosure regarding the Company's participation in the 2026 Raymond James Institutional Investors Conference held on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding an upcoming conference presentation rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the Company's intent to reaffirm previously issued guidance.
Guidance, Outlook, and Management Commentary
- Guidance Reaffirmation: Management will reaffirm the full-year 2026 financial guidance originally provided in the press release for the fourth quarter and full-year 2025, dated February 10, 2026.
- Forward-Looking Statements: The filing includes standard cautionary language noting that forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations.
- Risk Factors: Investors are directed to the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2025, for a detailed discussion of potential risks.
Investor Verification Checklist
- Verify the specific full-year 2026 guidance figures in the February 10, 2026, press release referenced in this filing.
- Review the "Risk Factors" in the 2025 Form 10-K to understand potential variables affecting the reaffirmed guidance.
- Confirm the date and details of the 2026 Raymond James Institutional Investors Conference presentation.